Karimunnisa Sameer Shaikh holds 4 issued patents and leads funded work on cochleate and transdermal platforms. She builds regulatory‑aligned nanomedicines—liposomes, micelles, nanoparticles—for oncology and beyond, uniting QbD analytics, in‑silico design, and in‑vivo validation across biopharmaceutics and biomedical engineering.